全文获取类型
收费全文 | 28209篇 |
免费 | 2771篇 |
国内免费 | 2240篇 |
专业分类
耳鼻咽喉 | 203篇 |
儿科学 | 311篇 |
妇产科学 | 314篇 |
基础医学 | 3681篇 |
口腔科学 | 476篇 |
临床医学 | 3865篇 |
内科学 | 4562篇 |
皮肤病学 | 247篇 |
神经病学 | 1442篇 |
特种医学 | 1000篇 |
外国民族医学 | 21篇 |
外科学 | 2932篇 |
综合类 | 4426篇 |
现状与发展 | 9篇 |
一般理论 | 4篇 |
预防医学 | 1725篇 |
眼科学 | 717篇 |
药学 | 2846篇 |
32篇 | |
中国医学 | 1491篇 |
肿瘤学 | 2916篇 |
出版年
2024年 | 108篇 |
2023年 | 493篇 |
2022年 | 1277篇 |
2021年 | 1631篇 |
2020年 | 1219篇 |
2019年 | 968篇 |
2018年 | 1066篇 |
2017年 | 908篇 |
2016年 | 870篇 |
2015年 | 1372篇 |
2014年 | 1684篇 |
2013年 | 1328篇 |
2012年 | 2004篇 |
2011年 | 2250篇 |
2010年 | 1362篇 |
2009年 | 1075篇 |
2008年 | 1403篇 |
2007年 | 1470篇 |
2006年 | 1393篇 |
2005年 | 1521篇 |
2004年 | 896篇 |
2003年 | 796篇 |
2002年 | 743篇 |
2001年 | 617篇 |
2000年 | 618篇 |
1999年 | 685篇 |
1998年 | 515篇 |
1997年 | 470篇 |
1996年 | 394篇 |
1995年 | 359篇 |
1994年 | 284篇 |
1993年 | 163篇 |
1992年 | 225篇 |
1991年 | 168篇 |
1990年 | 147篇 |
1989年 | 135篇 |
1988年 | 153篇 |
1987年 | 101篇 |
1986年 | 96篇 |
1985年 | 71篇 |
1984年 | 41篇 |
1983年 | 34篇 |
1982年 | 28篇 |
1981年 | 21篇 |
1980年 | 10篇 |
1979年 | 18篇 |
1978年 | 5篇 |
1975年 | 3篇 |
1971年 | 5篇 |
1969年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
991.
Liang Jing Jiang Yutong Huang Yefei Huang Yulan Liu Feng Zhang Yanli Yang Mingcan Wu Jialing Xiao Min Cao Shuangyan Gu Jieruo 《Clinical rheumatology》2021,40(7):2873-2880
Clinical Rheumatology - The objective was to identify the comorbidities of gout, to compare gender difference and independent factors of frequent gout attacks (> 20 times). Demographic,... 相似文献
992.
Wu Nan Shao Yuming Huo Jianwei Zhang Yanan Cao Yihan Jing Hongli Zhang Fa Yu Chenyang Yu Yanying Li Chen Song Hongmei Zhang Wen 《Clinical rheumatology》2021,40(4):1487-1495
Clinical Rheumatology - Pediatric SAPHO syndrome is regarded as the equivalent of chronic recurrent multifocal osteomyelitis or chronic non-bacterial osteomyelitis. This study aimed to evaluate the... 相似文献
993.
Rongzhong Huang Suetonia C. Palmer Yu Cao Hong Zhang Yang Sun Wenhua Su Liwen Liang Sanrong Wang Ying Wang Yu Xu Narayan D. Melgiri Lihong Jiang Giovanni F.M. Strippoli Xingsheng Li 《The Canadian journal of cardiology》2021,37(1):162-171
BackgroundCardiac rehabilitation is a medically supervised program after coronary events that involves exercise and dietary modification. We evaluated the comparative benefits and harms of cardiac rehabilitation strategies via a network meta-analysis.MethodsWe followed a pre-specified protocol (PROSPERO: CRD42018094998). We searched Embase, MEDLINE, and Cochrane Central Register of Randomized Trials databases for randomized controlled trials that evaluated cardiac rehabilitation vs a second form of rehabilitation or standard/usual care in adults after myocardial infarction, coronary artery bypass grafting, percutaneous coronary intervention, or angiography. Risk of bias and evidence quality was evaluated using the Cochrane tool and Grading of Recommendations Assessment, Development and Evaluation (GRADE), respectively. Pairwise and Bayesian network meta-analyses were performed for 11 clinical outcomes.ResultsWe included 134 randomized controlled trials involving 62,322 participants. Compared with standard care, exercise-only cardiac rehabilitation reduced the odds of cardiovascular mortality (odds ratio [OR], 0.70; 95% credibility interval [CrI], 0.51-0.96; moderate-quality evidence), major adverse cardiovascular events (OR, 0.57; 95% CrI, 0.40-0.78; low-quality evidence), nonfatal myocardial infarction (OR, 0.71; 95% CrI, 0.54-0.93; moderate-quality evidence), all-cause hospitalization (OR, 0.74; 95% CrI, 0.54-0.98; moderate-quality evidence), and cardiovascular hospitalization (OR, 0.69; 95% CrI, 0.51-0.88; moderate-quality evidence). Exercise-only cardiac rehabilitation was associated with lower cardiovascular hospitalization risk relative to cardiac rehabilitation without exercise (OR, 0.68; 95% CrI, 0.48-0.97; moderate-quality evidence).ConclusionsCardiac rehabilitation programs containing exercise might provide broader cardiovascular benefits compared with those without exercise. 相似文献
994.
目的: 分析2009—2020年合肥市肺结核疫情特征及空间聚集性。方法: 通过收集“中国疾病预防控制信息系统”的子系统“结核病管理信息系统”中合肥市2009—2020年肺结核数据,筛选出肺结核患者42681例,利用GeoDa和Arcgis 10.8空间分析软件进行分析,在街道/乡镇水平上绘制空间分布地图,探索空间分布规律及肺结核发病冷热点地区。结果: 2009—2020年合肥市肺结核共报告42681例,报告发病率从2009年57.96/10万(4195/7237966)下降到2020年31.04/10万(2908/9369881),整体呈现波动下降趋势($\chi _{趋势}^{2}$=12.531,P<0.001);全局空间自相关结果显示2009—2014年合肥市肺结核发病呈现空间自相关性(Moran’s I值均>0,P值均<0.05);2015—2020年空间分布偏向随机性。局部自相关分析显示高-高聚集发病街道/乡镇主要集中在长丰县、肥东县;低-低聚集区主要集中在老城区(庐阳区、包河区)。冷热点分析发现,热点区域有2个,分布在长丰县义井乡和肥西县严店乡。结论: 合肥市肺结核疫情存在一定的聚集性,后续应针对不同的县(区)街道/乡镇特点采取不同的防控措施,加大高-高聚集区的街道和热点区域的防控力度。 相似文献
995.
目的 比较猪尾型鼻胆引流管改制的新型胆管塑料支架与普通胆管塑料支架在姑息治疗肝门部胆管癌中的有效性和安全性。方法 收集2018年6月—2020年12月于北部战区总医院内窥镜科因肝门部胆管癌导致的梗阻性黄疸行经内镜逆行胰胆管造影术姑息性治疗的38例患者资料,其中20例患者使用猪尾型鼻胆引流管改制支架(新型组),18例患者使用普通塑料支架(普通组)。随访至2021年5月30日,比较两组的操作时间、住院时间、术后胆管炎发生率、胆红素下降水平、支架通畅时间等指标。结果 新型组和普通组的操作时间分别为(19.85±1.07) min和(22.00±3.38) min, 差异无统计学意义(t=1.26,P=0.607)。新型组和普通组的住院时间分别为(11.45±2.39)d和(11.33±3.51) d,差异无统计学意义(t=-0.52,P=0.938)。新型支架与普通支架术后第5天较术前总胆红素降低幅度中位数分别为122.85 μmol/L 和 96.25 μmol/L,差异有统计学意义(Z=-2.03,P=0.042)。新型组远期胆管炎发生率低于普通组[10.0%(2/20)比44.4%(8/18)],差异有统计学意义(P=0.027)。新型组支架引流通畅时间高于普通组[(109.45±32.67)d比(82.11±20.95)d],差异有统计学意义(t=2.23,P=0.032)。结论 相比普通胆管塑料支架,猪尾型鼻胆引流管改制的新型胆管塑料支架在姑息性治疗肝门部胆管梗阻时,可降低远期胆管炎发生率、延长胆管支架通畅期。 相似文献
996.
目的 评价内镜超声(endoscopic ultrasound,EUS)引导弹簧圈栓塞联合内镜组织胶注射治疗合并较大自发性分流道的胃底静脉曲张的疗效和安全性。方法 回顾性分析武汉大学人民医院2016年12月—2020年12月因胃底静脉曲张伴较大自发性分流道(分流道最窄处直径5~15 mm)接受EUS引导弹簧圈栓塞联合内镜组织胶注射的24例患者资料,统计并分析短期疗效(技术成功率、术后5 d再出血率、6周死亡率)、远期疗效(1年再出血率和死亡率、3年死亡率)及安全性(异位栓塞发生率)。结果 EUS引导弹簧圈栓塞联合内镜组织胶注射技术成功率91.7%(22/24),5 d再出血率0(0/22)。1例(4.5%)术后2 d复查门静脉系统血管CT成像显示脾静脉主干部分栓塞。22例患者中2例失访,随访时间14.9(1.0~48.6)个月,术后6周死亡率0(0/20),术后1年再出血率35.0%(7/20)。12例行胃镜随访的患者中,5例出现不同程度食管静脉曲张加重,5例出现不同程度门静脉高压性胃病加重。术后1年死亡率5.0%(1/20),术后3年死亡率20.0%(4/20),均与出血及异位栓塞事件无关。结论 对于合并较大自发性分流道的胃底静脉曲张患者,EUS引导弹簧圈栓塞联合内镜组织胶注射治疗短期安全有效,并能降低异位栓塞发生风险,远期疗效及安全性仍有待进一步证实。 相似文献
997.
Liu-Liu Cao Mei Peng Xiang Xie Gong-Quan Chen Shu-Yan Huang Jia-Yu Wang Fan Jiang Xin-Wu Cui Christoph F Dietrich 《World journal of gastroenterology : WJG》2022,28(27):3398-3409
Artificial intelligence (AI) is playing an increasingly important role in medicine, especially in the field of medical imaging. It can be used to diagnose diseases and predict certain statuses and possible events that may happen. Recently, more and more studies have confirmed the value of AI based on ultrasound in the evalua tion of diffuse liver diseases and focal liver lesions. It can assess the severity of liver fibrosis and nonalcoholic fatty liver, differentially diagnose benign and malignant liver lesions, distinguish primary from secondary liver cancers, predict the curative effect of liver cancer treatment and recurrence after treatment, and predict microvascular invasion in hepatocellular carcinoma. The findings from these studies have great clinical application potential in the near future. The purpose of this review is to comprehensively introduce the current status and future perspectives of AI in liver ultrasound. 相似文献
998.
Wen-Shu Hu Fang-Ying Jiang Wen Shu Rong Zhao Ji-Min Cao De-Ping Wang 《World journal of gastroenterology : WJG》2022,28(47):6716-6731
Coronavirus disease 2019 (COVID-19), caused by infection with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has escalated into a global tragedy afflicting human health, life, and social governance. Through the increasing depth of research and a better understanding of this disease, it has been ascertained that, in addition to the lungs, SARS-CoV-2 can also induce injuries to other organs including the liver. Liver injury is a common clinical manifestation of COVID-19, particularly in severe cases, and is often associated with a poorer pro gnosis and higher severity of COVID-19. This review focuses on the general existing information on liver injury caused by COVID-19, including risk factors and subpopulations of liver injury in COVID-19, the association between pre existing liver diseases and the severity of COVID-19, and the potential mechanisms by which SARS-CoV-2 affects the liver. This review may provide some useful information for the development of therapeutic and preventive strategies for COVID-19-associated liver injury. 相似文献
999.
目的:探析孕妇羊水过少对妊娠并发症与围生儿的影响。方法选取2012年7月—2014年7月在我院接受治疗的羊水过少产妇84例作为观察组,同时选取84例羊水量正常的在我院分娩的产妇作为对照组,对比两组产妇妊娠并发症、围生期婴儿情况。结果观察组产妇的围生儿出现胎内窘迫、羊水粪染、新生儿窒息以及围生儿死亡的例数均显著高于对照组,对比差异显著,具有统计学意义(P<0.05);同时,在观察组羊水过少的84例孕妇中,伴有妊娠并发症者49例显著高于对照组伴有妊娠并发症者8例,且观察组胎儿生长受限、过期妊娠、妊娠高血压、胎儿畸形以及其他并发症的发生情况均显著高于对照组,组间对比有明显差异,具有统计学意义(P<0.05)。结论羊水过少严重影响着产妇妊娠并发症的发生、围生儿的健康状况。也就是说,羊水过少,妊娠并发症的发生率越高。 相似文献
1000.
Wan-Ting Cao Rong Huang Ke-Fang Jiang Xue-Hui Qiao Jing-Jing Wang Yi-Hong Fan Yi Xu 《World journal of gastroenterology : WJG》2021,27(9):886-907
BACKGROUND Although blood concentration of biologics is an important composition of disease management in inflammatory bowel disease(IBD)patients,complexity and uncertainty of biological management encourage many disputes in predicting the outcome of IBD patients through blood concentration of biologics.AIM To verify the predictive value of blood concentration of biologics on endoscopic inactivity in IBD patients under different situations.METHODS We searched PubMed/MEDLINE,Embase,and Web of Science up to May 2020 and identified IBD patients as the research cohort as well as the correlations between blood concentration of biologics and endoscopic inactivity in IBD patients as the research direction.RESULTS A total of 23 articles with 30 clinical studies and 1939 IBD patients were included.The predictive cut-off value of blood concentration of infliximab on mucosal healing should be 2.7-10.6μg/mL in IBD.Blood concentration of infliximab reaching 5.0-12.7μg/mL or more increased the probability of fistula healing/closure in perianal fistulizing Crohn's disease.Blood concentration of adalimumab reaching 7.2-16.2μg/mL or more could predict mucosal healing in IBD.The predictive cut-off value of blood concentration of adalimumab on fistula healing/closure should be 5.9-9.8μg/mL in perianal fistulizing Crohn's disease.Blood concentration of vedolizumab surpassing 25.0μg/mL indicated mucosal healing in ulcerative colitis patients under maintenance therapy and the predictive cut-off value of blood concentration on mucosal healing or endoscopic remission under induction therapy in IBD could be 8.0-28.9μg/mL.CONCLUSION Blood concentration of biologics should not be utilized to predict endoscopic inactivity of IBD independently due to discrepancies in clinical studies,whereas conducting therapeutic drug monitoring intensively contributes to precise therapy. 相似文献